Literature DB >> 8805742

Influence of the assessment of defect severity and intravenous nitrate administration during tracer injection on the detection of viable hibernating myocardium with data-based quantitative technetium 99m-labeled sestamibi single-photon emission computed tomography.

R Sciagrà1, G Bisi, G M Santoro, M Agnolucci, O Zoccarato, P F Fazzini.   

Abstract

BACKGROUND: This study aimed to verify whether the assessment of defect severity and the infusion of nitrates during tracer injection improve the capability of data-based 99mTc-labeled sestamibi single-photon emission computed tomography (SPECT) to recognize hibernating myocardium. METHODS AND
RESULTS: Of 66 asynergic coronary territories in 40 patients with left ventricular dysfunction, 28 had postrevascularization functional recovery (hibernating) and 38 had unchanged dysfunction (fibrotic). Defect severity was lower in the hibernating than in the fibrotic territories on both baseline (p < 0.01) and nitrate SPECT (p < 0.002). Nitrate was superior to baseline SPECT to differentiate the hibernating from the fibrotic territories (sensitivity 96% vs 75%, p < 0.05; receiver-operating characteristic curve area 0.75 vs 0.63, p < 0.001) and to identify the patients with improved left ventricular ejection fraction (receiver-operating characteristic curve area 0.68 vs 0.58; p < 0.05).
CONCLUSIONS: The analysis of defect severity in combination with nitrate infusion clearly improves the value of 99mTc-labeled sestamibi SPECT for the recognition of hibernating myocardium and the prediction of postrevascularization recovery.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8805742     DOI: 10.1016/s1071-3581(96)90036-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  20 in total

1.  Evaluation of techniques for the elimination of "hot" bladder artifacts in SPECT of the pelvis.

Authors:  M K O'Connor; B J Kelly
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

2.  Optimal specificity of thallium-201 SPECT through recognition of imaging artifacts.

Authors:  E G DePuey; E V Garcia
Journal:  J Nucl Med       Date:  1989-04       Impact factor: 10.057

3.  A quantitative comparison of attenuation-weighted backprojection with multiplicative and iterative postprocessing attenuation compensation in SPECT.

Authors:  S H Manglos; R J Jaszczak; C E Floyd; L J Hahn; K L Greer; R E Coleman
Journal:  IEEE Trans Med Imaging       Date:  1988       Impact factor: 10.048

4.  An investigation of the magnitude and causes of count loss artifacts in SPECT imaging.

Authors:  G J Gillen; B Gilmore; A T Elliott
Journal:  J Nucl Med       Date:  1991-09       Impact factor: 10.057

5.  Correction of nonuniform attenuation in cardiac SPECT imaging.

Authors:  B M Tsui; G T Gullberg; E R Edgerton; J G Ballard; J R Perry; W H McCartney; J Berg
Journal:  J Nucl Med       Date:  1989-04       Impact factor: 10.057

6.  Investigation of causes of geometric distortion in 180 degrees and 360 degrees angular sampling in SPECT.

Authors:  K Knesaurek; M A King; S J Glick; B C Penney
Journal:  J Nucl Med       Date:  1989-10       Impact factor: 10.057

7.  Nonisotropic attenuation in SPECT: phantom tests of quantitative effects and compensation techniques.

Authors:  S H Manglos; R J Jaszczak; C E Floyd; L J Hahn; K L Greer; R E Coleman
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

8.  Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects.

Authors:  M L Bartlett; S L Bacharach; L M Voipio-Pulkki; V Dilsizian
Journal:  J Nucl Med       Date:  1995-02       Impact factor: 10.057

9.  Rapid back to back adenosine stress/rest technetium-99m teboroxime myocardial perfusion SPECT using a triple-detector camera.

Authors:  T Chua; H Kiat; G Germano; K Takemoto; G Fernandez; Y Biasio; J Friedman; D Berman
Journal:  J Nucl Med       Date:  1993-09       Impact factor: 10.057

10.  A study of the liver-heart artifact in emission tomography.

Authors:  J Nuyts; P Dupont; V Van den Maegdenbergh; S Vleugels; P Suetens; L Mortelmans
Journal:  J Nucl Med       Date:  1995-01       Impact factor: 10.057

View more
  5 in total

Review 1.  Imaging techniques in nuclear cardiology for the assessment of myocardial viability.

Authors:  Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A J O Dierckx; Pieter L Jager
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-13       Impact factor: 2.357

2.  Myocardial viability: strengthening the evidence base.

Authors:  Terrance Chua
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11       Impact factor: 9.236

Review 3.  Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?

Authors:  B Caner; G A Beller
Journal:  Clin Cardiol       Date:  1998-04       Impact factor: 2.882

Review 4.  Diagnostic and imaging considerations: role of viability.

Authors:  Roxy Senior
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

5.  Direct imaging of viable myocardium by gated SPECT in patients with ischaemic left ventricular dysfunction.

Authors:  Marco Spadafora; Paola Varrella; Wanda Acampa; Marco Spirito; Carmela Nappi; Luigi Mansi; Paolo Miletto; Giuseppe Rosato; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-24       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.